|
|
Volumn 102, Issue 1, 2011, Pages 1-3
|
|
SIMD commentary on FDA oversight of laboratory-developed testing
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA DETERMINATION;
FOOD AND DRUG ADMINISTRATION;
GENETIC SCREENING;
HEALTH PRACTITIONER;
HUMAN;
INBORN ERROR OF METABOLISM;
LABORATORY TEST;
MEDICAL SOCIETY;
MORBIDITY;
MORTALITY;
NEWBORN SCREENING;
NOTE;
PRIORITY JOURNAL;
CLINICAL CHEMISTRY TESTS;
CLINICAL LABORATORY TECHNIQUES;
GENETIC TESTING;
METABOLISM, INBORN ERRORS;
RISK ASSESSMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 78650905902
PISSN: 10967192
EISSN: 10967206
Source Type: Journal
DOI: 10.1016/j.ymgme.2010.11.157 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
